# Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery

Study · id `cardio:ct-nct07499154` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT07499154](<https://clinicaltrials.gov/study/NCT07499154>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT07499154

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 320 participants.

## Technical summary

Registry record NCT07499154. Randomized; quadruple masking; primary purpose prevention. Start 2026-04-01 (anticipated); primary completion 2027-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 320 participants (planned count; ClinicalTrials.gov record NCT07499154, source copy `cardio:ctgov-nct07499154-2026-03-30`, retrieved 2026-10-26)
- Planned start: 2026-04-01 (anticipated) (ClinicalTrials.gov record NCT07499154, source copy `cardio:ctgov-nct07499154-2026-03-30`, retrieved 2026-10-26)
- Primary completion: 2027-12-01 (anticipated) (ClinicalTrials.gov record NCT07499154, source copy `cardio:ctgov-nct07499154-2026-03-30`, retrieved 2026-10-26)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT07499154, source copy `cardio:ctgov-nct07499154-2026-03-30`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT07499154, source copy `cardio:ctgov-nct07499154-2026-03-30`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct07499154-2026-03-30`, retrieved 2026-10-26)

## The registry's words

- Brief title: Perioperative Lidocaine for Lung Protection in Infants Undergoing Cardiac Surgery
- Acronym: PLICS
- Condition: Congenital Heart Disease
- Condition: Postoperative Pulmonary Complications
- Condition: Acute Lung Injury
- Intervention (Drug): Lidocaine %2 ampoule
- Intervention (Drug): Normal Saline (0.9% NaCl)
- Lead sponsor: The Children's Hospital of Zhejiang University School of Medicine
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Congenital heart disease (`core:congenital-heart-disease`)

## Provenance

Content hash: c63a4be390b8276d33dfa22b3f6230c50179ff6270f924a38e0be0c94a5be2db
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
